The demand for big-ticket IPOs had helped the primary market raise a record Rs 1.18 lakh crore in the calendar year.

Two issues, Paras Defence & Space Technologies and GR Infraprojects, soared 175 per cent and 103 per cent, respectively, more than doubling...

The Edelweiss Recently Listed IPO Fund didn’t participate in most of this year’s new offers as many didn’t meet the criteria for valuations...

Data showed out of 22 listings so far in 2021, 16 managed to deliver double-digits returns to investors, while eight shot up in excess of 5...

Out of the 30 companies, 13 have delivered over 100 per cent return since listing. The list featured Route Mobiles, Happiest Minds and Tech...

Shares of little-known companies that make products, services in heavy use in second wave rising sharply in volatile market

The second wave of the pandemic has increased demand for products like oximeters, thermometers, BP monitors, nebulisers and multivitamins, ...

Some of these IPOs received 'subscribe' ratings for listing gains from top brokerages despite aggressive valuations.

MTAR is looking to sell 1.037 crore shares through a mix of fresh issue and offer for sale. The bidding process for the IPO will commence o...

Grey market trends suggest the stock indeed may see decent listing gains, but that may not be enough for it to replicate Nureca's performan...

At the issue price, the stock was priced at a P/E of 62.55 times on its earnings per share of Rs 6.40.

India’s drug regulator has not cleared the application of Dr Reddy’s Laboratories seeking approval to market the Sputnik V Covid-19 vaccine...

The issue, which was sold from February 15 to February 17, had received a solid 166.65 times retail bids.

Shares of some of the IPO aspirants are already performing decently in unlisted market, as the secondary market benchmarks almost doubled f...

The IPO comprises issuance of equity shares worth Rs 100 crore, a draft red herring prospectus filed with Securities and Exchange Board of ...

Proceeds of the issue will be used for funding incremental working capital requirements of the company and general corporate purposes.